Fit Biotech Oy
Records under this name other than patents Fit Biotech Oy holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 6 of 6 · Back to Fit Biotech Oy
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,474,800 | Expression vector encoding alphavirus replicase and the use thereof as immunological adjuvant Lapsed on the fee record Ended Oct 25, 2024 · USPTO record | Lapsed on the fee record | Ended Oct 25, 2024 | USPTO record |
| US 9,725,486 | Methods of treating HIV diseases using novel expression vectors Lapsed on the fee record Ended Aug 8, 2021 · USPTO record | Lapsed on the fee record | Ended Aug 8, 2021 | USPTO record |
| US 7,521,182 | Selection system containing non-antibiotic resistance selection marker Lapsed on the fee record Ended Apr 21, 2021 · USPTO record | Lapsed on the fee record | Ended Apr 21, 2021 | USPTO record |
| US 7,510,718 | Expression vectors and uses thereof Lapsed on the fee record Ended Mar 31, 2021 · USPTO record | Lapsed on the fee record | Ended Mar 31, 2021 | USPTO record |
| US 7,498,314 | Expression vectors and uses thereof Lapsed on the fee record Ended Mar 3, 2021 · USPTO record | Lapsed on the fee record | Ended Mar 3, 2021 | USPTO record |
| US 6,479,279 | Episomal vectors and uses thereof Term ended Term ended Dec 29, 2015 · USPTO record | Term ended | Term ended Dec 29, 2015 | USPTO record |